Fabrinet (FN) Q3 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Garo Toomajanian - VP - IR & Corporate DevelopmentSeamus Grady - CEOCsaba Sverha - CFOKarl Ackerman - Managing Director - Equity ResearchSamik Chatterjee - Executive DirectorSteven Fox - Founder & CEOGeorge Wang - Vice President Conference Call Participants Mike Genovese - Senior Research AnalystRyan Koontz - Senior AnalystTim Savageaux - MD & Senior Research Analyst Operator Good afternoon. Welcome to Fabrinet's Financial Res ...

Ethan Allen Interiors (ETD) Q3 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Matt McNulty - Senior VP, Treasurer & CFOFarooq Kathwari - Chairman, President & CEOBrad Thomas - Associate Director of Research Conference Call Participants Cristina Fernández - Managing Director & Senior Equity Research Analyst Operator Good afternoon, and welcome to the Ethan Allen Fiscal twenty twenty five Third Quarter Analyst Conference Call. At this time, all participants are in a listen only mode. A quest ...

Digimarc (DMRC) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants George Karamanos - Executive VP, Chief Legal Officer & SecretaryRiley McCormack - CEO, President & DirectorCharles Beck - EVP, CFO & Treasurer Conference Call Participants Joshua Reilly - Senior AnalystJeff Van Rhee - Partner & Senior Analyst - Equity Research Operator Greetings, and welcome to the Digimarc Q1 twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A question an ...

Certara (CERT) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants David Deuchler - IRWilliam Feehery - CEOJohn Gallagher - Chief Financial OfficerDaniel Clark - VP - Equity ResearchScott Schoenhaus - Managing DirectorDavid Windley - Managing DirectorJeff Garro - Managing DirectorChristine Rains - Healthcare Equity Research AssociateConstantine Davides - Managing DirectorJacqueline Kisa - Equity Research AssociateParth Patel - Equity Research Associate Conference Call Participants Joe Vruwin ...

Corcept Therapeutics (CORT) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Atabak Mokari - Chief Financial OfficerSean Maduck - President of EndocrinologyCharles Robbins - Chief Business OfficerJoseph Belanoff - Chief Executive Officer, President and DirectorRoberto Vieira - President - OncologyWilliam Guyer - Chief Development Officer Conference Call Participants Edward Nash - MD & Senior Biotechnology AnalystDavid Amsellem - Sr. Research AnalystJoon Lee - Director & Senior Biotech Ana ...

Financial Data and Key Metrics Changes - First quarter revenue was $682 million, up 13% year over year, with growth in both segments [23] - Adjusted EBITDA was $130 million, also up 13% year over year, driven by robust growth in government operations [23] - Adjusted earnings per share increased to $0.91, a 20% rise compared to $0.76 last year [24] - Free cash flow for the quarter was $17 million, with capital expenditures at $33 million, or 4.9% of sales [26] Business Line Data and Key Metrics Changes - Government operations revenue grew by 14%, with adjusted EBITDA reaching $117 million and a margin of 21.1% [27] - Commercial operations revenue was $128 million, up 10% year over year, with adjusted EBITDA of $14 million and a margin of 10.9% [28] - The backlog for commercial operations reached a record $1.3 billion, up 39% from the previous quarter and 78% year over year [17] Market Data and Key Metrics Changes - The U.S. government continues to prioritize naval nuclear fleet and nuclear modernization, creating opportunities for BWXT [7][12] - In Canada, significant investments are being made in nuclear generation capacity, with potential new builds expanding to nearly 20 gigawatts [18] Company Strategy and Development Direction - BWXT is focused on expanding its nuclear services portfolio and enhancing manufacturing capacity in North America [9] - The company is well-positioned to capitalize on long-term investments in clean nuclear power and energy security [6] - The acquisition of Connectrix and expansion of the Cambridge manufacturing plant are part of the strategy to meet growing customer demand [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to weather macroeconomic disruptions due to long-cycle contracts and a strong balance sheet [10] - The administration's focus on nuclear energy and shipbuilding is seen as a positive for future growth [46] - Management anticipates a modest growth outlook for government operations in 2025, with a revenue CAGR of 3% to 5% in the naval propulsion segment [12] Other Important Information - The company completed the acquisition of AOT and is actively pursuing opportunities in the special materials sector [14] - BWXT is involved in the Advanced Nuclear Power for Installations Program, which aims to provide energy security for U.S. military bases [15] Q&A Session Summary Question: Negative EACs impact on government operations - Management confirmed that negative EACs were split between commercial and government operations, with recovery expected in the second half of the year [35][36] Question: Funding opportunities from recent appropriations - Management indicated limited direct funding opportunities from the continuing resolution but expressed optimism about potential benefits from the reconciliation bill [39][40] Question: Updates on the reconciliation package and shipbuilding - Management noted funding for defense enrichment and nuclear reactors in the reconciliation bill, with a positive outlook for nuclear shipbuilding [44][46] Question: Impact of raw material costs on commercial operations - Management acknowledged that raw material cost issues would affect margins in the first half of the year but expected recovery in the second half [48][49] Question: Timeline for Moly approval and contracting - Management hopes for approval in 2025 but acknowledged potential delays into early 2026 [56][57] Question: Updates on the enrichment contract and pilot program - Management detailed the conceptual stage of the pilot plant and the complexities of using unobligated materials for enrichment [65][68] Question: BWXT's entry into SPR management - Management highlighted their experience and qualifications as key factors in winning the SPR management contract [99][100] Question: Progress on Actinium-225 production - Management confirmed they remain the largest commercial producer of Actinium-225 and are exploring multiple production modalities [102][104]

Financial Data and Key Metrics Changes - The company generated $88 million in revenue and $57 million in cash from operations for Q1 2025, aligning with expectations [6][19] - Adjusted EBITDA for Q1 was $47.3 million, reflecting an adjusted EBITDA margin of 54% [21] - The company ended the quarter with $116.5 million in cash, cash equivalents, and marketable securities [22] Business Line Data and Key Metrics Changes - Recurring revenue for Q1 2025 increased modestly year-over-year, with non-pay TV segments seeing a 25% increase [8][9] - The company signed 10 license agreements in Q1, including four with new customers in key growth areas such as social media, OTT, and semiconductors [9][10] - Renewals accounted for a significant portion of revenue stability, with over 90% of customers renewing their agreements [13] Market Data and Key Metrics Changes - The company noted strong momentum in the OTT market, with significant opportunities both domestically and internationally [41] - The semiconductor market is seeing growth driven by the adoption of hybrid bonding technologies [14][40] Company Strategy and Development Direction - The company maintains a balanced capital allocation strategy and focuses on growth in OTT, semiconductors, and adjacent media markets [7][14] - The strategic acquisition of patent portfolios is aimed at enhancing the company's media and semiconductor capabilities [17][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the business model despite macroeconomic volatility, with over 80% of revenue supported by contracted agreements [7][8] - The company reiterated its full-year 2025 revenue guidance of $390 million to $430 million, with expectations for operating expenses between $166 million and $174 million [24][25] Other Important Information - The company acquired two IP portfolios for $5 million, focusing on micro LEDs and imaging technologies [16][23] - A new board member, Sandeep Vizh, was nominated to replace retiring board member Raghu Rao [18] Q&A Session Summary Question: Potential for new sports league deals - Management expressed optimism about the new U.S. Professional Sports League deal, indicating it could lead to more opportunities in the sports sector [30][31] Question: Opportunities in sports betting - Management acknowledged the exploration of sports gambling as a potential adjacent market, though it is seen as a longer-term opportunity [33] Question: Licensing status of acquired portfolios - The acquired micro LED and imaging portfolios do not currently have existing licenses attached, but management sees significant potential for future revenue [35] Question: Semiconductor deal expectations - Management clarified that the recent semiconductor deal was not the large opportunity anticipated from the previous year, but it reflects ongoing progress in hybrid bonding adoption [40] Question: OTT market opportunities - Management indicated that the majority of OTT opportunities are domestic, with ongoing litigation affecting some potential deals [41] Question: Social media market potential - Management noted that the company has licensed approximately 90% of the social media market, with opportunities primarily in renewals rather than new deals [43]

Weave Communications (WEAV) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Mark McReynolds - Head of Investor RelationsBrett White - CEOJason Christiansen - CFOTimothy Greaves - Equity Research Associate Conference Call Participants Alex Sklar - AnalystBrent Bracelin - Sr. Research AnalystParker Lane - AnalystMichael Funk - Analyst Operator Ladies and gentlemen, greetings and welcome to the Vii First Quarter '20 '20 '5 Financial Results. At this time, all participants are in a listen on ...

ThredUp (TDUP) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Lauren Frasch - Senior Director, IR & Strategic FinanceJames Reinhart - Co-Founder, CEO & DirectorSean Sobers - CFODana Telsey - CEO and Chief Research OfficerKunal Madhukar - Managing Director Conference Call Participants Ike Boruchow - Managing Director: Senior Analyst - Retailing, Specialty Softlines and E-commerceDylan Carden - Research AnalystBernie Mcternan - Senior Research Analyst Operator Good afternoon, ladies and g ...

Syndax Pharmaceuticals (SNDX) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Sharon Klahre - VP - IR & Corporate CommunicationsMichael Metzger - CEO & DirectorSteve Closter - CCONeil Gallagher - President, Head of Research & DevelopmentKeith Goldan - Chief Financial OfficerPriyanka Grover - Vice President - Biotechnology Equity ResearchEllen Horste - Equity Research AssociatePeter Ordentlich - Co-Founder & Chief Scientific OfficerDavid Dai - DirectorYigal Nochomovitz - DirectorSalim Sye ...